Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome - A Monocentric, Prospective, Randomized, Double-blind and Placebo-controlled Phase 2 Trial

Trial Profile

Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome - A Monocentric, Prospective, Randomized, Double-blind and Placebo-controlled Phase 2 Trial

Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 May 2016

At a glance

  • Drugs Trichuris suis ova (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms TRIOMS
  • Most Recent Events

    • 05 May 2016 Status changed from completed to discontinued.
    • 31 Mar 2016 Status changed from recruiting to completed as per European Clinical Trials Database.
    • 16 Sep 2013 Planned end date changed from 1 Dec 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top